THIS CLINICAL ANSWER IS NEW Published Online: 19 MAY 2017
This Cochrane Clinical Answer evaluates gabapentin in people with amyotrophic lateral sclerosis/motor neuron disease.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.